Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.

Twiss J, McKenna S, Ganderton L, Jenkins S, Ben-L'amri M, Gain K, Fowler R, Gabbay E.

BMC Pulm Med. 2013 Jul 12;13:45. doi: 10.1186/1471-2466-13-45.

PMID:
23844640
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.

Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E.

Respirology. 2011 Nov;16(8):1235-40. doi: 10.1111/j.1440-1843.2011.02030.x.

PMID:
21810146
[PubMed - indexed for MEDLINE]
Free Article
3.

Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial.

Ganderton L, Jenkins S, Gain K, Fowler R, Winship P, Lunt D, Gabbay E.

BMC Pulm Med. 2011 May 23;11:25. doi: 10.1186/1471-2466-11-25.

PMID:
21600062
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Proteus mirabilis biofilms and the encrustation of urethral catheters.

Stickler D, Ganderton L, King J, Nettleton J, Winters C.

Urol Res. 1993;21(6):407-11.

PMID:
8171763
[PubMed - indexed for MEDLINE]
5.

Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters.

Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D.

Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):789-96.

PMID:
1468417
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk